Patents by Inventor Kathryn A. Hjerrild

Kathryn A. Hjerrild has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180215805
    Abstract: Provided herein is an isolated tumour necrosis factor receptor (TNFR) polypeptide capable of binding to TNF, or a TNF-binding fragment thereof, wherein the polypeptide comprises an amino acid sequence of SEQ ID NO:1, or an amino acid sequence that has at least 60% identity thereto and wherein the polypeptide or TNF-binding fragment comprises an N-terminal VPAQV motif (SEQ ID NO: 68), with the proviso that the polypeptide is not mouse TNFR p80 isoform. Also provided is a fusion protein comprising said polypeptide, or a TNF-binding fragment thereof, linked to a fusion partner, such as the CH2 and CH3 domains of an immunoglobulin heavy chain constant region. The polypeptides and fusion proteins disclosed herein may be used for diagnostic purposes and in the treatment or prevention of conditions mediated by TNF, particularly in non-human animals such as feline and equine.
    Type: Application
    Filed: January 29, 2016
    Publication date: August 2, 2018
    Inventors: Kathryn HJERRILD, David GEARING
  • Patent number: 7587284
    Abstract: Pieces of software and databases are used to facilitate the design and synthesis of genes. The synthesis techniques allow identification, quantification, transcription, translation, and manipulation of portions of the gene sequence represented as 0's and 1's in a computing system. These pieces of software and databases compile constraint information provided by a user to create synthetic genes to express proteins lacking disordered or variable regions and containing surface mutations that promote solubility and/or crystallization. Regions of the gene sequence that do not form stable structures can be removed and replaced by a short biological linker to improve crystallization of proteins.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: September 8, 2009
    Assignee: deCODE biostructures, Inc.
    Inventors: Lansing J. Stewart, Alex Burgin, John W. Walchli, Kathryn Hjerrild
  • Publication number: 20080131411
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Application
    Filed: April 16, 2007
    Publication date: June 5, 2008
    Applicant: UCB SA
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Patent number: 7220579
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Grant
    Filed: November 15, 2004
    Date of Patent: May 22, 2007
    Assignee: UCB SA
    Inventors: Mary E Brunkow, Eric W Jeffery, Kathryn A Hjerrild, Fred Ramsdell
  • Patent number: 7135612
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Grant
    Filed: September 3, 2004
    Date of Patent: November 14, 2006
    Assignee: UCB SA
    Inventors: Mary E Brunkow, Eric W Jeffery, Kathryn A Hjerrild, Fred Ramsdell
  • Publication number: 20060235626
    Abstract: Pieces of software and databases are used to facilitate the design and synthesis of genes. The synthesis techniques allow identification, quantification, transcription, translation, and manipulation of portions of the gene sequence represented as 0's and 1's in a computing system. These pieces of software and databases compile constraint information provided by a user to create synthetic genes to express proteins lacking disordered or variable regions and containing surface mutations that promote solubility and/or crystallization. Regions of the gene sequence that do not form stable structures can be removed and replaced by a short biological linker to improve crystallization of proteins.
    Type: Application
    Filed: January 24, 2006
    Publication date: October 19, 2006
    Inventors: Lansing Stewart, Alex Burgin, John Walchli, Kathryn Hjerrild
  • Publication number: 20050164247
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Application
    Filed: November 15, 2004
    Publication date: July 28, 2005
    Applicant: Celltech R & D Limited
    Inventors: Mary Brunkow, Eric Jeffery, Kathryn Hjerrild, Fred Ramsdell
  • Publication number: 20050106601
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Application
    Filed: September 3, 2004
    Publication date: May 19, 2005
    Applicant: Celltech R & D Limited
    Inventors: Mary Brunkow, Eric Jeffery, Kathryn Hjerrild, Fred Ramsdell
  • Patent number: 6884618
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Grant
    Filed: April 2, 2002
    Date of Patent: April 26, 2005
    Assignee: Darwin Discovery Ltd.
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Patent number: 6794145
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: September 21, 2004
    Assignee: Darwin Discovery Ltd.
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Patent number: 6683160
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Assays that are based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), may be used for identifying numerous molecules that modulate the immune system. Molecules that specifically bind to an Fkhsf polypeptide are also provided as useful, such as, for modulating the biological activities of Fkhsf. In particular, antibodies that are specific for Fkhsf polypeptide are provided for uses such as for detecting the expression of an Fkhsf polypeptide in cells, isolating an Fkhsf polypeptide, and modulating the activity of an Fkhsf polypeptide.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: January 27, 2004
    Assignee: Darwin Discovery Limited
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Patent number: 6683171
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: January 27, 2004
    Assignee: Darwin Discovery Ltd.
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Patent number: 6667162
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: December 23, 2003
    Assignee: Darwin Discovery Limited
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Publication number: 20020168736
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors.
    Type: Application
    Filed: April 2, 2002
    Publication date: November 14, 2002
    Applicant: Darwin Discovery Ltd.
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
  • Patent number: 6414129
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors.
    Type: Grant
    Filed: August 11, 1999
    Date of Patent: July 2, 2002
    Assignee: Darwin Discovery Ltd.
    Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell